Category: CannabisNewsWire Release

Zoned Properties Inc. (ZDPY) Emerges as a Crucial Partner for the Cannabis Industry; Announced Planned $1 Million Share Buyback

  • Cannabis retail dispensaries in Arizona have grown to upwards of 168 locations as of January 2024
  • Nonetheless, only 1% of Arizona’s commercial properties are eligible for use by the cannabis industry
  • Zoned Properties has been a key partner for the industry in helping cannabis companies establish a physical retail presence
  • The company has recently announced the approval of a $1 million share buyback plan

The legalized sale of recreational cannabis in Arizona has grown from strength to strength. Possession and cultivation of cannabis across the state became legal on November 30, 2020, with the state-licensed sale of recreational cannabis commencing on January 22, 2021 making Arizona the quickest state in U.S. history to begin retail sales post recreational legalization. Cannabis sales in the state drove over $1.4 billion in revenues in 2023, with the number of dispensaries swelling to 292 as of January 2024 (https://cnw.fm/UyEP2). Nevertheless, further expansion for the industry is easier said than done; at present, only 1 percent of Arizona’s commercial real estate properties are applicable to cannabis operators, imposing a further constraint on the growth and development of the state’s cannabis retail market.

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company focused on acquiring value-add real estate within the regulated cannabis industry in the United States, has been amongst the early leaders in facilitating the transition of the cannabis industry towards the physical retail space. The company maintains a portfolio of six investment properties located across Arizona, Michigan and Illinois; with each of its leased properties occupied by commercial cannabis-linked businesses, the company currently enjoys a 100% occupancy rate with a weighted average lease term of over 10 years.

Zoned Properties has been amongst the leaders in identifying and procuring registered cannabis facilities, which can subsequently be sub-leased to the cannabis industry. Bryan McLaren, Chairman and CEO of Zoned Properties elaborated on the company’s methodology during a recent interview with the Bell2Bell podcast (https://cnw.fm/DSBPc).

“Our company and our team go into these state marketplaces and we identify, qualify and get these properties approved that can be utilized as regulated cannabis facilities. In the best-case scenario, what we’re doing is securing a piece of retail real estate – an old bank, an old restaurant, an old quick service retail location – getting that property approved to be used as a cannabis site called a retail dispensary and leasing that property out to a third-party tenant with a cannabis license in that location under a long-term lease agreement.”

Zoned Properties’ unique business model has translated into a faster rate of operational growth, with the company recently revealing that it had acquired a further two sites for use as potential dispensary locations. Separately, the company has looked to combine its ambitious focus on growth with a desire to maximise total shareholder returns; Zoned Properties recently announced that its Board of Directors has approved a stock repurchase program, pursuant to which the company was authorized to purchase up to $1 million of its common stock over an unlimited time period (https://cnw.fm/wivYQ).

“As our business continues to outperform in a challenging overall operating environment, we are thrilled to announce this share repurchase program. The approval of this program demonstrates the management teams and board’s confidence in our prospects for the future, ongoing operational strength, and sound capital structure,” stated McLaren. “As we scale the investment portfolio, we are keeping conservative in our capital allocation strategy while also acknowledging the significant valuation gap between our public valuation and tangible book value. Due to this, it is crucial for us to be adaptable and make sure we are doing everything possible to increase shareholder value. As always, we remain committed in our strategic focus, and look forward to updating shareholders on our progress,” he continued.

For more information, visit the company’s website at www.ZonedProperties.com.

NOTE TO INVESTORS: The latest news and updates relating to ZDPY are available in the company’s newsroom at https://cnw.fm/ZDPY

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Signature Collection Can Begin After North Dakota Cannabis Legalization Ballot Initiative Gains Official Approval

Michael Howe, North Dakota’s secretary of state, recently gave the green light for the circulation of a petition aiming to legalize marijuana. If approved, the measure would allow adults aged 21 and older to grow, process, use and sell cannabis. Additionally, it would establish a regulatory body to oversee marijuana-related entities within the state.

The proposal also includes specific regulations concerning processing and production, as well as restrictions on usage, such as in vehicles and public spaces, and provisions for home cultivation.

To qualify for inclusion on the ballot, supporters of the petition must gather a minimum of 15,582 signatures by April 25 next year. Should they meet this deadline by July 8 this year, the legislation will be put to a vote in November’s general election. However, if the required signatures are collected after this date but before next year’s deadline, the legislation will be deferred to the next statewide election, anticipated to occur in 2026.

An advertisement posted on Indeed reveals that advocates of the proposal are seeking North Dakotans to assist in petition circulation across various cities, including Dickinson, Bismarck, Devils Lake, Grand Forks, Fargo, Jamestown, Williston and Minot.

Spearheading the initiative is Steve Bakken, a former mayor of Bismarck and current Burleigh County commissioner. Bakken underlined the need for more efficient use of resources, particularly in the fight against illegal drugs and substances such as fentanyl. He also emphasized the group’s goal of averting the possible adoption of a badly written initiative.

In previous years, voters in the state have rejected similar measures to legalize cannabis, with 55% opposing the proposal in 2022 and an even larger margin against it in 2018. Despite these setbacks, in 2021, the state’s House passed legislation aimed at legalizing and taxing recreational cannabis. However, these efforts were thwarted by the GOP-led senate.

Voters approved medical cannabis in 2016, leading to the establishment of a state-run program that currently serves about 10,000 patients. Additionally, the state’s Pardon Advisory Board introduced a new procedure to streamline pardons for minor cannabis offenses in 2019, resulting in 100 pardons by Governor Doug Burgum.

Currently, 24 states have legalized recreational cannabis, with Ohio being the most recent to do so through a ballot initiative last year. Additionally, similar initiatives are being carried out in other states. Florida is scheduled to vote on a ballot measure in November, and there are active signature-collection campaigns in states including South Dakota, Nebraska and Arkansas.

The opportunity for voters in North Dakota to end marijuana prohibition will likely be watched by industry companies such as Canopy Growth Corp. (NASDAQ: CGC) (TSX: WEED) because the enactment of a law creating a marijuana market would give residents the choice to consume marijuana for recreational purposes much like it is happening in other states around the country.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Golden Triangle Ventures Inc. (GTVH) New Acquisition Takes Lavish Division One Step Closer to Development of Premier Music, Art Destination

  • More than half of Americans have attended a music festival, indicating lucrative potential for music and art destinations
  • GTVH recently closed on the acquisition of ABI Create, a premier event-management and production company
  • With the invaluable resources ABI Create brings to the table, the future of Destino Ranch looks more promising than ever

With Coachella still fresh in music lovers’ memories, it’s only natural to look at what other amazing music festivals might be looming in the future. Destino Ranch comes to mind. A new project focused on becoming an international destination where nature and technology combine to create unforgettable experiences such as outstanding music festivals, Destino Ranch is being developed by Golden Triangle Ventures (OTC: GTVH) and its entertainment division, Lavish Entertainment.

Officially called the Coachella Valley Music and Arts Festival, Coachella is held over two weekends at the Empire Polo Club in Indio, California, in the Coachella Valley in the Colorado Desert. The event traditionally features an array of musical artists from different music genres, including rock, pop, indie, hip hop and more; the festival also includes art installations and sculptures.

This year, Coachella saw record attendance, with organizers reporting an estimated 300,000 people flocking to Indio (https://cnw.fm/kBJIS). In addition, Coachella’s revenue is impressive, bringing in $115 million collectively from ticket, food and beverage sales and generating around $700 million for the local economy in Indio and surrounding cities each year (https://cnw.fm/t2t9R).

There’s definitely an eager audience for events such as music and art festivals. In fact, a Marketing Chart study reported that “overall, roughly one-third (34%) of American adults surveyed report having been to more than one music festival, while an additional fifth (20%) say they’ve been once. As such, some 54% of U.S. adults have been to at least one music festival” (https://cnw.fm/gphBd).

Clearly, Golden Triangle Ventures and Lavish Entertainment are on to something. Most recently the company took a significant step forward in the development of Destino Ranch with the acquisition of ABI Create, a premier event-management and production company (https://cnw.fm/QmBvF). Founded by Marco Antonio Moreno, who was recently named president and COO of Lavish Entertainment, ABI Create has delivered high-quality productions for a range of large-scale installations at major music festivals, sporting events and conventions across the United States, including the NFL Super Bowl, San Diego and New York Comic Con events, EDC and Camp EDC, Bonnaroo Music Festival, the Waste Management Phoenix Open, Arnold Palmer Invitational, Burning Man and more.

The completed acquisition will transition ABI Create into a wholly owned subsidiary of Lavish Entertainment, strengthening Lavish’s position in the entertainment industry through ABI’s well-known reputation and proven track record of executing high-level projects. Headquartered in Las Vegas, ABI’s comprehensive suite of services includes event organization, management, production, logistics, site planning, permitting, construction, contracting, custom design and fabrication.

With the invaluable resources ABI Create brings to the table, the future of Destino Ranch looks more promising than ever. With access to nearly 22,000 visitors traveling through the area every day, the ranch could quickly become a modern art and music festival mecca. In fact, current plans call for the destination location to include an immersive, world-class art installation gallery with rotating exhibits as well as a large-scale music venue with state-of-the-art staging and production, all carefully designed to complement the beautiful natural attributes of the surrounding Mojave Desert.

“This acquisition of ABI Create sets the stage for us to begin showcasing all other synergistic divisions within Lavish that will support all resources, relationships and partnerships within the ABI portfolio of offerings,” said Steffan Dalsgaard, CEO of Golden Triangle Ventures. “Our goal is to develop ABI into a one-stop-shop, event-management business within Lavish that will hold a complete suite of event management and development services. This aims to complement all internal projects and productions and will potentially support outside business opportunities that can provide fundamental synergies to our ultimate plan of building a complete entertainment enterprise.”

Golden Triangle Ventures is a multifaceted consulting company that operates as a parent business pursuing ventures in the health, entertainment and technology sectors, as represented by the three-point golden triangle, along with other sectors that provide synergistic value to these three core divisions. The company aims to purchase, acquire and/or joint venture with established entities within these areas of business. The goods and services represented are driven by innovators who have passion and commitment in these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services.

For more information, visit the company’s website at www.GoldenTriangleInc.com.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://cnw.fm/GTVH

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting the Massive Type 2 Diabetes and Obesity Markets with its DehydraTECH(TM) Technology

  • Lexaria, a global innovator in drug delivery platforms, through its patented DehydraTECH(TM) technology, looks to address the growing type 2 diabetes and obesity problem
  • Given the success of previous studies, the company is looking to double down on glucagon-like peptide 1 (“GLP-1”) studies for 2024
  • GLP-1 treatments are a major player in managing weight and addressing diabetes, and Lexaria’s DehydraTECH(TM) drug delivery platform has the potential of replacing painful and expensive GLP-1 injections with an effective oral delivery path
  • The company has already received independent ethics review board approval for its GLP-1 human pilot study #2, a milestone that brings it closer to offering a tolerable oral delivery option for diabetes treatment

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recognizes the tremendous potential in the treatment of type 2 diabetes and obesity, and looks to address it through its patented DehydraTECH(TM) drug delivery technology that offers improved delivery of bioactive compounds. The confidence in its technology, as evidenced by the success of previous clinical studies, has allowed it to double down on glucagon-like peptide 1 (“GLP-1”) studies for the 2024 calendar year. The company is optimistic that the studies will yield positive results, not just in the potential treatment of diabetes but also in weight management, which has been directly linked to diabetes.

According to the Centers for Disease Control and Prevention (“CDC”), more than one in three Americans today are at increased risk for type 2 diabetes. This represents about 98 million Americans, with 81% not knowing they are at such a risk (https://cnw.fm/5ROKd). Studies showed a massive spike in overall incidences of type 2 diabetes between 2002 and 2018, with one of the main cited risk factors being obesity. The CDC noted that of those diagnosed with the condition, 89.8% of them were overweight or obese, as defined by a body mass index (“BMI”) of 25 kg/m2 or higher. This was further compounded by physical inactivity, with 31.9% of those diagnosed reporting getting less than 10 minutes a week of moderate or vigorous activity (https://cnw.fm/onJuB).

In March, Lexaria announced details of its upcoming 12-week animal study WEIGHT-A24-1 that will examine diabetes and weight loss effects of DehydraTECH-processed GLP-1 drugs and DehydraTECH-processed cannabidiol, alone and in combination (https://cnw.fm/9yxZw). Results will guide additional human investigations.

The company recently received independent third-party ethics review board approval for its GLP-1 human pilot study #2, seeking to explore the oral delivery of GLP-1 drugs. For Lexaria, this marks a significant milestone that brings it closer to offering a more effective and tolerable oral delivery option for diabetes treatment and weight loss management (https://cnw.fm/oDqd6).

“Most GLP-1 drugs sold today are administered by painful and expensive injection devices. More effective and tolerable oral delivery of GLP-1 drugs could be extremely valuable to patients and to industry,” noted Chris Bunka, Lexaria’s CEO.

“I am excited about this study; the Lexaria scientific team believes that a dissolvable oral tablet that delivers an effective fraction of semaglutide along with reduced side effects could potentially offer valuable benefits to the pharmaceutical industry that might lead to a higher likelihood of favorable strategic partnering with leading industry players in GLP-1,” he added.

Previous Lexaria studies have demonstrated that DehydraTECH processing results in higher brain absorption than non-DehydraTECH arms. Already, GLP-1R agonists have been shown to penetrate the brain and activate a subset of GLP-1R-expressing neurons in the arcuate nucleus to produce weight loss. With the upcoming studies, Lexaria looks to evidence that DehydraTECH processing of GLP-1 drugs can enable even faster penetration into brain tissue, ultimately improving overall efficiency in weight loss and blood sugar control. Its management is optimistic that it will replicate the success of previous studies and looks forward to kickstarting the undertaking.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — German Marijuana Imports Reached Record Levels in 2023

Germany saw a significant surge in its marijuana imports for scientific and medical purposes last year, reaching a record high, indicating a growing interest from international businesses eyeing opportunities in Europe’s largest federally regulated medical cannabis market. According to the latest data from the Federal Institute for Drugs & Medical Devices (BfArM), the country imported 36.4 tons (31,398 kilograms) of marijuana products last year. This marks a notable increase of 26.2% compared to the previous year’s import volume of 24,876 kilograms.

The trend of increasing imports has been consistent through the years. In 2022, the country saw imports of 27.4 tons (24,876 kilograms) of marijuana, reflecting a 19.8% increase from the previous year. The year 2021 saw imports of 22.9 tons (20,771 kilograms), representing a significant surge of 77% over the previous year.

In 2020, imports totaled 12.8 tons (11,746 kilograms), indicating a 46% increase from 2019, while in 2019, Germany imported 8.9 tons (8,057 kilograms) of marijuana, which was an 80% increase from the previous year’s imports. While some of these imports are re-exported to other European Union countries annually, experts suggest that the data underscores the rapid growth of the industry.

Only three businesses were authorized to grow medical cannabis in 2019; these companies were given strict output targets that would last for four years. Due to this restriction, cannabis had to be imported from overseas to meet demand. However, changes in marijuana law have the potential to reduce its dependence on imports in the future. The new law eliminates the quota system, allowing companies to apply for permits to grow medical cannabis through the agency.

Furthermore, the recent revision of the marijuana law, effective April 1, 2024, has reclassified the substance, removing it from the list of narcotics. This regulatory change simplifies the process for patients seeking medical marijuana because they will no longer be required to have a narcotic prescription form. Standard prescriptions will now suffice, likely stimulating demand in the market.

Despite the optimism for increased domestic cultivation, Germany is expected to continue relying on significant imports in the foreseeable future. German-based Demecan’s managing director, Von der Groeben, pointed out Article 21 of the UN Single Convention on Narcotic Drugs, which suggests that domestic demand must be met before imports can be halted. However, he acknowledges that achieving self-sufficiency in marijuana production may take several years.

Canada remained the primary supplier of marijuana to the German market last year, accounting for approximately 50% of imports. Portugal came in second, while the Netherlands was the third-largest supplier.

The further easing of marijuana laws in Germany could create additional opportunities that major players in the North American cannabis landscape, such as Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), may look to exploit as they expand their footprint in different legal markets.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches New Research Program to Evaluate DehydraTECH-GLP-1 Drugs

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced an applied research program to evaluate certain molecular characteristics of DehydraTECH processed with the glucagon-peptide 1 (“GLP-1”) drug, semaglutide, related to its mode of action and performance. According to the announcement, the research will be conducted in partnership with the National Research Council of Canada (“NRC”). “We are excited about our partnership with the NRC for the mode of action molecular characterization of DehydraTECH-GLP-1 drugs. This work program could potentially provide data to assist Lexaria’s efforts in partnering with the pharmaceutical industry for the most rapid introduction possible of DehydraTECH with GLP-1 drugs,” said John Docherty, president of Lexaria. “The NRC was selected for this important work program because of its high-caliber research facilities and capabilities, further building upon the previous history of successful research projects between Lexaria and the NRC.”

To view the full press release, visit https://cnw.fm/DYsJy

About Lexaria Bioscience Corp.

DehydraTECH(TM) is Lexaria’s patented drug delivery formulation and processing platform technology that improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream through oral delivery. Since 2016, Lexaria has developed and investigated DehydraTECH with a variety of beneficial molecules in oral and topical formats. DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption and has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier, which Lexaria believes to be of particular importance for centrally active compounds. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 41 patents granted and many patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

BizCann Expo 2024 by ZJ Events, is Coming to Latin America

Date: May 18-19, 2024
Venue: Plaza Mayor, Medellin Colombia

ZJ Events brings BizCann Expo to Latin America, hosting the BizCann Expo 2024 in Medellin, Colombia, May 18-19, 2024. This event promises to boost cannabis investments and offer phenomenal cannabis business avenues in the region. The BizCann Expo 2024 conference offers cannabis traders, entrepreneurs, legislators, enthusiasts, and influencers, two days of networking, innovation, business, and education on the cannabis industry.

The BizCann Expo 2024 is a premier event that will connect the leading American cannabis markets for better opportunities. It will boost cannabis trade by offering a networking platform to all the cannabis businesses from all segments. 30+ eminent speakers of the industry will present insightful sessions covering the latest trends, hurdles, legislations, regulations, as well the innovations in this field.

BizCann Expo 2024 has partnered with well-known brands, from plant touching, non-plant touching, as well as ancillary services in the canna industry. The wide gamut of speakers comprises of manufacturers, professionals, service providers, legislators, software and accounting wizards, all catering to the cannabis industry.

The attendee list consists of growers, entrepreneurs, C-level executives, accountants, legal advisors, investors as well as newbies developing a foothold in the Latin American cannabis industry. Attendees can connect with the industry people and build their own cannabis community, and will also gain insights into the legal and licensing aspects of business. During the networking sessions, they can connect with industry veterans and peers to establish long-term business ties across the American landscape.

With its proximity to the US, Colombia offers the perfect venue for the expo. In addition, Medellin has great connecting facilities, a favourable legislation framework, and a vibrantly rich culture and history.

To know more, please visit https://cnw.fm/rUlkW.

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Citrus-Smelling Cannabis Compound Has Potential to Manage THC-Induced Paranoia

Cannabis, when used in the right amount, can have calming effects, easing anxiety and alleviating pain. However, determining the appropriate dosage can be challenging. Consuming even slightly too much can lead to a starkly different experience, often referred to as “paranoia” by recreational users, characterized by panic and acute anxiety.

Recent research published in Drug and Alcohol Dependence suggests that one of the aromatic compounds in marijuana, d-limonene, may counteract these anxiety-causing effects. The citrusy compound, found naturally in marijuana, could potentially help users avoid experiencing anxiety attacks, which would increase cannabis’ therapeutic effects.

Marijuana contains more than 500 chemical components, with THC being the primary psychoactive component responsible for the “high.” Additionally, cannabinoids such as CBD are thought to influence the overall experience. Terpenes, aromatic compounds in marijuana, contribute to its unique scent. There’s a longstanding belief in the cannabis community that ingesting products created from the entire plant rather than isolated compounds, including CBD or THC, produces a different, more beneficial effect, a concept known as the entourage effect.

However, the scientific evidence for the effect remains unclear due to the many chemicals involved. Ryan Vandrey, a behavioral pharmacologist at Johns Hopkins University, explains that, despite the lack of conclusive evidence for the entourage effect, it has significantly influenced how marijuana strains are bred and marketed. This concept originated partly from studies suggesting that terpenes such as d-limonene may have anxiety-reducing properties, as indicated in a review paper in 2011 by Ethan Russo.

To investigate whether d-limonene could indeed alleviate THC-induced anxiety, Vandrey and his team conducted a double-blind study involving participants who had previously experienced anxiety while using marijuana. The results showed that increasing concentrations of d-limonene relative to THC led to fewer reported symptoms of anxiety, suggesting a potential therapeutic effect. This effect was most significant when participants inhaled a high ratio of d-limonene to THC, a ratio not typically found in natural marijuana strains.

However, Vandrey cautioned about the preliminary nature of these findings and the need for further research. While d-limonene appears to target anxiety specifically without affecting other aspects of the marijuana high, its mechanism of action remains unclear. Additionally, the study’s limitations, such as using vaporized marijuana and high concentrations of d-limonene, need to be addressed in future studies.

Despite these limitations, the study opens the door to further exploration of terpenes’ role in marijuana effects. Researchers are already investigating other terpenes found in marijuana to better understand their impact.

The potential of terpenes such as d-limonene isn’t entirely new. Folk remedies dating back centuries suggest that compounds found in citrus fruits could counteract the negative effects of cannabis. While these remedies have historical backing, scientific research is just beginning to uncover their true potential.

The entire cannabis industry, including leading companies such as Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY), could pay attention to the outcomes of any additional studies exploring the effects of d-limonene because it could open new opportunities for custom cannabis products.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — New Survey: 6 in 10 Americans Consider Cannabis Safer Than Tobacco, Alcohol

According to a new survey, the majority of Americans believe that marijuana is less detrimental to health than tobacco and alcohol. According to the YouGov poll, 64% of participants believe that regular alcohol consumption is riskier than marijuana use, and 63% believe that regular tobacco use is also riskier. The survey conducted from April 5–8, 2024, involved 1,148 adults.

Contrastingly, only a small fraction — 14% — believes that cannabis usage poses a greater threat than regular alcohol consumption. Additionally, 16% of participants stated that marijuana is more detrimental than tobacco. In total, 53% of those surveyed indicated that both tobacco and alcohol are more detrimental to health than cannabis.

These findings align with other recent surveys, such as one conducted by Gallup, which revealed that Americans generally perceive cannabis as less detrimental than cigarettes, alcohol and vaping. Moreover, the survey noted that marijuana use has overtaken cigarette consumption in the United States while vaping is currently behind both.

Similarly, a JAMA poll published last year indicated a shift in public perception, with more people considering smoking cannabis or secondhand marijuana smoke exposure as safer compared to tobacco smoke.

The YouGov poll also revealed that a significant majority of Americans — 62% — support marijuana legalization. This sentiment cuts across political affiliations, with 46% of Republicans, 67% of independents and 71% of Democrats expressing support for legalization.

Regarding usage patterns, 56% admitted to trying cannabis in their lifetime, with 24% reporting consumption within the past year and 17% within the last 30 days. Among those who consumed marijuana in the past year, 24% used it several times daily, 11% used it once daily and 20% used it occasionally.

According to the survey, smoking bud or flower was the most popular (61%) form of use among those who have tried cannabis or CBD. Furthermore, if cannabis were to be legalized countrywide, 67% of nonusers stated that they would keep abstaining. Another 14% expressed uncertainty about trying it, while 6% said they likely would, and 2% said they certainly would.

Meanwhile, another recent survey revealed that more than one-half of the adult population was surprised by the fact that cannabis remains federally illegal in the United States.

Furthermore, a Pew Research Center survey found that 90% of Americans support the legalization of cannabis for either medical or recreational purposes. Most respondents stated that legalization enhances equity in the criminal justice system and helps the local economy.

As perceptions toward marijuana keep changing, cannabis companies such as SNDL Inc. (NASDAQ: SNDL) could see their clientele growing in the different markets in which they have operations.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

BizCann Expo Brings Cannabis Business to Latin America

BizCann invites traders, vendors, entrepreneurs, regulatory authorities, investors, and cannabis enthusiasts, to attend the BizCann Expo being held in Medellin, Colombia, May 18-19, 2024. The BizCann Expo is organized by ZJ Events, bringing the businesses and professionals of the cannabis industry and its ancillaries to a common forum for networking, trading, and learning sessions.

Having spread its reach over several cities in the US, BizCann Expo is being held in Medellin, Colombia, this year to offer phenomenal trading opportunities to local businesses. Due to its favorable location, connectivity, and rich history, Medellin offers the perfect venue for hosting this networking event.

In the year 2023, the event witnessed 50+ speakers, 200+ vendors, and 5,000+ attendees who connected over two days of networking and learning at the BizCann Expo. This year the participation is expected to outgrow last year’s numbers. Industry professionals with fresh and unique ideas can leverage this expo forum to gain visibility among peers, industry giants, and investors.

Entrepreneurs and creative minds with unique business ideas can share their innovations on this platform. Several eminent industry leaders will attend the expo to discuss the latest updates and strategies for successful canna trading. Plant-touching and non-plant touching cannabis businesses will also be represented at the Expo.

The speaker sessions will be conducted by stalwarts of the cannabis industry who have years of knowledge and experience of trading in this industry. They will discuss the latest updates, regulations, challenges, and prospects that lay ahead for businesses to grow and prosper. (Applications for speaker sessions are open.)

To learn more, please visit https://cnw.fm/fsryx

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN